Aptose Biosciences Statistics Share Statistics Aptose Biosciences has 2.55M
shares outstanding. The number of shares has increased by 23.09%
in one year.
Shares Outstanding 2.55M Shares Change (YoY) 23.09% Shares Change (QoQ) 19.08% Owned by Institutions (%) 7.27% Shares Floating 499.77K Failed to Deliver (FTD) Shares 23,530 FTD / Avg. Volume 10.41%
Short Selling Information The latest short interest is 69.83K, so 0% of the outstanding
shares have been sold short.
Short Interest 69.83K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.87
Valuation Ratios The PE ratio is -1.18 and the forward
PE ratio is -0.3.
Aptose Biosciences's PEG ratio is
0.05.
PE Ratio -1.18 Forward PE -0.3 PS Ratio 0 Forward PS 0.1 PB Ratio -6.61 P/FCF Ratio -0.83 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aptose Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.14,
with a Debt / Equity ratio of -2.34.
Current Ratio 2.14 Quick Ratio 2.14 Debt / Equity -2.34 Debt / EBITDA n/a Debt / FCF -0.3 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-726.57K Employee Count 35 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -84.3% in the
last 52 weeks. The beta is 1.13, so Aptose Biosciences's
price volatility has been higher than the market average.
Beta 1.13 52-Week Price Change -84.3% 50-Day Moving Average 3.17 200-Day Moving Average 8.68 Relative Strength Index (RSI) 41.45 Average Volume (20 Days) 225,970
Income Statement
Revenue n/a Gross Profit n/a Operating Income n/a Net Income -25.43M EBITDA n/a EBIT n/a Earnings Per Share (EPS) -5.73
Full Income Statement Balance Sheet The company has 6.15M in cash and 10.64M in
debt, giving a net cash position of -4.49M.
Cash & Cash Equivalents 6.15M Total Debt 10.64M Net Cash -4.49M Retained Earnings -540.97M Total Assets 5.59M Working Capital -5.73M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -35.98M
and capital expenditures -5K, giving a free cash flow of -35.98M.
Operating Cash Flow -35.98M Capital Expenditures -5K Free Cash Flow -35.98M FCF Per Share -8.1
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields APTO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for APTO is $6,
which is 250.9% higher than the current price. The consensus rating is "Strong Buy".
Price Target $6 Price Target Difference 250.9% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 26, 2025. It was a
backward
split with a ratio of 1:30.
Last Split Date Feb 26, 2025 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -132.75 Piotroski F-Score 2
